Insider and Congress filings

DaVita Inc. (DVA)

Medical Care Facilities, listed on NYSE.

S&P 500369 insider transactions41 Congress tradeslast filed Oct 29, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Oct 29, 2026

DaVita beat by 7.0% on adjusted EPS.

$3.82 a share against a $3.57 consensus. Revenue $3.58B against $3.52B, a beat of 1.7%.

EPS

Reported$3.82
Consensus$3.57

Revenue

Reported$3.58B
Consensus$3.52B

Beat 5Miss 1

EPS against the consensus, quarter by quarter. Outlined: a GAAP figure against an adjusted consensus.

Next report Feb 1, 2027. Consensus $4.14 a share.

Every quarter

Money managers13F filings for Sep 30, 2026

91

institutions reported DaVita shares in 13F filings for Sep 30, 2026. BlackRock, Inc. held the largest stake, $478.2M.

The largest holders

BlackRock, Inc.$478.2M
Vanguard Capital Management LLC$395.2M
Morgan Stanley$287.2M
Every holder

Insider tradesForm 4 · 12 open-market filings shown

12 open-market sales.

Jan 29, 2026Oct 27, 2026

Sales

A median 2 business days from trade to filing. Form 4 is due within two.

Every filing

CongressSTOCK Act disclosures to the House and Senate

20 Congress disclosures shown, from 5 members.

33dMedian delayof the 45 day limit
5 buys · 15 sellsPurchases and sales in the disclosures shown

2 members of Congress report a position in DVA, by our estimate. Who holds it

Every Congress trade in DVAEvery disclosure
Companyfrom the company's filings and listing, as of Nov 15, 2026

About DaVita Inc.

Exchange
NYSE
Sector
Healthcare
Industry
Medical - Care Facilities
Chief executive
Javier J. Rodriguez
Employees
78,000
Listed since
Oct 31, 1995
Market value
$11.0B
Price to earnings (12 mo)
13.4
Net income per share, as reported (12 mo)
$14.41
Dividend yield
-

www.davita.com

Earnings6 reported quarters · next on Feb 1, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Oct 29, 2026$3.82$3.57$3.6B$3.5BEPS beatRevenue beat
Q2 FY2026reported Aug 4, 2026$4.02$3.88$3.6B$3.5BEPS beat, GAAPRevenue beat
Q1 FY2026reported May 5, 2026$2.87$2.41$3.4B$3.4BEPS beat, GAAPRevenue beat
Q4 FY2025reported Feb 2, 2026$3.40$3.24$3.6B$3.5BEPS beatRevenue beat
Q3 FY2025reported Oct 29, 2025$2.51$3.17$3.4B$3.4BEPS missRevenue in line
Q2 FY2025reported Aug 5, 2025$2.95$2.70$3.4B$3.4BEPS beatRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

No earnings call briefs on DVA yet. Briefs from every company we cover.

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on DVA, newest first
FirmRatingTargetActionDate
UBSBuy$287Raised from $270
Truist SecuritiesHold$215Cut from $250
Deutsche BankNot stated$265Raised from $220
BarclaysEqual Weight$224Raised from $218

Each firm's latest target from the past year, with the rating stated with its note. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.

1 other firm rated DVA in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 16, 2026.

Proxy statementas filed for fiscal 2025 · proxy filed Apr 22, 2026

Executive pay

Javier J. Rodriguez’s pay as CEO came to $18.2M for fiscal 2025.
ExecutiveSalaryStock awardsOtherTotal
Javier J. RodriguezChief Executive Officer$1.5M$11.4M$5.3M$18.2M
Joel AckermanChief Financial Officer and Treasurer$835K$3.6M$1.7M$6.1M
David P. MaughanChief Operating Officer, DaVita Kidney Care$725K$3.2M$1.7M$5.6M
Kathleen A. WatersChief Legal and Public Affairs Officer$750K$2.0M$1.2M$3.9M
James O. HeartyChief Compliance Officer$600K$720K$642K$2.0M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

13F filings13F positions as of Sep 30, 2026

Institutional holders

HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$478.2M2,733,890+11.1%4.22%
Vanguard Capital Management LLC$395.2M2,259,222+7.5%3.49%
Morgan Stanley$287.2M1,641,878+2.5%2.53%
Vanguard Portfolio Management LLC$275.3M1,573,788+14.2%2.43%
Invesco Ltd.$249.4M1,425,674+17.6%2.20%
State Street Corp$241.0M1,377,835+4.1%2.13%
Geode Capital Management, LLC$219.3M1,255,164+47.0%1.94%
Dimensional Fund Advisors LP$209.2M1,195,898+5.1%1.85%
Arrowstreet Capital, Limited Partnership$204.5M1,169,087+31.5%1.80%
Neuberger Berman Group LLC$169.0M966,006+4.4%1.49%
LSV Asset Management$152.2M869,916-4.2%1.34%
UBS Group AG$108.0M617,288+102.3%0.95%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Sep 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Form 412 filings shown · newest filing first

Open-market insider trades

InsiderActionSharesPriceValueTrade dateDelay
(business days)
Berkshire Hathaway Inc10% ownerSold382,563$180.43$69.0MOct 27, 2026filed Oct 29, 20262d
Berkshire Hathaway Inc10% ownerSold182,980$199.55$36.5MJul 31, 2026filed Aug 4, 20262d
Javier RodriguezChief Executive OfficerSold39,407$209.28$8.2MJun 16, 2026filed Jun 17, 20261d
Javier RodriguezChief Executive OfficerSold30,000$209.50$6.3MJun 15, 2026filed Jun 17, 20262d
Kathleen Alyce WatersChief Legal & Pub. Affairs OffSold · 2 lines15,405$208.40$3.2MJun 15, 2026filed Jun 17, 20262d
James O. HeartyChief Compliance OfficerSold15,000$193.98$2.9MMay 15, 2026filed May 18, 20261d
David Paul MaughanChief Operating Officer, DKCSold13,456$199.25$2.7MMay 12, 2026filed May 13, 20261d
David Paul MaughanChief Operating Officer, DKCSold7,073$199.15$1.4MMay 11, 2026filed May 13, 20262d
Joel AckermanCFO and TreasurerSold51,471$192.10$9.9MMay 7, 2026filed May 11, 20262d
James O. HeartyChief Compliance OfficerSold2,184$174.87$382KMay 6, 2026filed May 8, 20262d
Berkshire Hathaway Inc10% ownerSold1,220,376$149.84$182.9MMay 1, 2026filed May 5, 20262d
Berkshire Hathaway Inc10% ownerSold1,658,480$120.56$199.9MJan 29, 2026filed Feb 2, 20262d

One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.

Other Form 4 activity (20)
InsiderEventSharesDate
David Paul MaughanChief Operating Officer, DKCTax withholding7,501Sep 22, 2026
Phyllis R. YaleDirectorStock award278Aug 15, 2026
Pamela M. ArwayDirectorStock award278Aug 15, 2026
Wendy Lee SchoppertDirectorStock award278Aug 15, 2026
Dennis W. PullinDirectorStock award278Aug 15, 2026
Gregory J. MooreDirectorStock award278Aug 15, 2026
Adam H. SchechterDirectorStock award278Aug 15, 2026
Barbara J. DesoerDirectorStock award278Aug 15, 2026
Jason M. HollarDirectorStock award278Aug 15, 2026
Phyllis R. YaleDirectorGift5,038May 26, 2026
James O. HeartyChief Compliance OfficerTax withholding1,117May 14, 2026
James O. HeartyChief Compliance OfficerDisposed to issuer3,231May 14, 2026
James O. HeartyChief Compliance OfficerOption exercise5,784May 14, 2026
Jason M. HollarDirectorStock award250May 15, 2026
Adam H. SchechterDirectorStock award250May 15, 2026
Barbara J. DesoerDirectorStock award250May 15, 2026
Phyllis R. YaleDirectorStock award250May 15, 2026
Pamela M. ArwayDirectorStock award250May 15, 2026
Wendy Lee SchoppertDirectorStock award250May 15, 2026
Gregory J. MooreDirectorStock award250May 15, 2026

Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.

STOCK Act20 disclosures of 41 on record · median 33d of the 45 allowed

Congress trades in DVA

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Julie JohnsonJointFiled lateStockSale$1,001 - $15,000+31.4% since the saleEstimated exit price $132.83, close on Tue Sep 23, 2025Current price $174.56, close on Fri Nov 13Sep 23, 2025Aug 5, 2026316d
Julie JohnsonJointFiled lateStockPurchase$1,001 - $15,000+31.4% since the tradeEstimated entry price $132.83, close on Tue Sep 23, 2025Current price $174.56, close on Fri Nov 13Sep 23, 2025Aug 5, 2026316d
Alan ArmstrongSelfStockPurchase$1,001 - $15,000+13.0% since the tradeEstimated entry price $154.43, close on Fri Mar 27Current price $174.56, close on Fri Nov 13Mar 27, 2026Jul 21, 2026116d
Julie JohnsonJointStockSale$1,001 - $15,000+34.0% since the saleEstimated exit price $130.27, close on Thu Sep 25, 2025Current price $174.56, close on Fri Nov 13Sep 25, 2025Oct 7, 202512d
Ro KhannaStockSale$1,001 - $15,000+26.6% since the saleEstimated exit price $137.87, close on Fri Sep 5, 2025Current price $174.56, close on Fri Nov 13Sep 5, 2025Oct 3, 202528d
Ro KhannaStockPurchase$1,001 - $15,000+27.7% since the tradeEstimated entry price $136.66, close on Wed May 28, 2025Current price $174.56, close on Fri Nov 13May 28, 2025Jun 10, 202513d
Jerry MoranSpouseStockSale (Full)$1,001 - $15,000+62.9% since the saleEstimated exit price $107.18, close on Thu Dec 14, 2023Current price $174.56, close on Fri Nov 13Dec 14, 2023Jan 17, 202434d
Ro KhannaStockSale$1,001 - $15,000+76.6% since the saleEstimated exit price $98.83, close on Thu Jun 29, 2023Current price $174.56, close on Fri Nov 13Jun 29, 2023Jul 11, 202312d
Ro KhannaStockPurchase$1,001 - $15,000+74.0% since the tradeEstimated entry price $100.33, close on Fri May 19, 2023Current price $174.56, close on Fri Nov 13May 19, 2023Jun 12, 202324d
Ro KhannaStockSale$1,001 - $15,000+129.3% since the saleEstimated exit price $76.12, close on Fri Mar 24, 2023Current price $174.56, close on Fri Nov 13Mar 24, 2023Apr 7, 202314d
Jerry MoranSelfStockSale (Partial)$1,001 - $15,000+60.4% since the saleEstimated exit price $108.86, close on Tue Dec 21, 2021Current price $174.56, close on Fri Nov 13Dec 21, 2021Jan 21, 202231d
Michael T. McCaulStockSale$15,001 - $50,000+140.7% since the saleEstimated exit price $72.51, close on Thu Dec 5, 2019Current price $174.56, close on Fri Nov 13Dec 5, 2019Jan 29, 202055d
Michael T. McCaulStockSale$15,001 - $50,000+142.1% since the saleEstimated exit price $72.11, close on Mon Dec 9, 2019, the first after the Sun Dec 8, 2019 tradeCurrent price $174.56, close on Fri Nov 13Dec 8, 2019Jan 29, 202052d
Michael T. McCaulStockSale$15,001 - $50,000+140.3% since the saleEstimated exit price $72.63, close on Wed Dec 11, 2019Current price $174.56, close on Fri Nov 13Dec 11, 2019Jan 29, 202049d
Michael T. McCaulStockSale$15,001 - $50,000+140.8% since the saleEstimated exit price $72.48, close on Mon Dec 16, 2019Current price $174.56, close on Fri Nov 13Dec 16, 2019Jan 29, 202044d
Michael T. McCaulStockSale$15,001 - $50,000+222.1% since the saleEstimated exit price $54.20, close on Tue Oct 8, 2019Current price $174.56, close on Fri Nov 13Oct 8, 2019Nov 14, 201937d
Michael T. McCaulStockSale$1,001 - $15,000+212.7% since the saleEstimated exit price $55.82, close on Thu Oct 10, 2019Current price $174.56, close on Fri Nov 13Oct 10, 2019Nov 14, 201935d
Michael T. McCaulStockSale$15,001 - $50,000+206.2% since the saleEstimated exit price $57.01, close on Wed Oct 16, 2019Current price $174.56, close on Fri Nov 13Oct 16, 2019Nov 14, 201929d
Michael T. McCaulStockSale$1,001 - $15,000+201.7% since the saleEstimated exit price $57.85, close on Thu Oct 17, 2019Current price $174.56, close on Fri Nov 13Oct 17, 2019Nov 14, 201928d
Michael T. McCaulStockPurchase$15,001 - $50,000+241.9% since the tradeEstimated entry price $51.05, close on Wed Apr 17, 2019Current price $174.56, close on Fri Nov 13Apr 17, 2019May 15, 201928d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in DVA filterable by party, chamber, type and account.

STOCK Act2 members · estimate, as of Nov 15, 2026

Members of Congress reporting a position

2 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$1,001 - $15,000<0.1%
Robert BresnahanRepublican · House$1,001 - $15,0000.1%

The largest estimated position is in the $1,001 - $15,000 band. Estimate, as of Nov 15, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 16, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on DVA show and how current they are.

Are insiders buying or selling DVA?

Across the 12 most recent open-market filings shown here, 0 were purchases and 12 were sales.

Which members of Congress have traded DVA?

Julie Johnson, Alan Armstrong, Ro Khanna, Jerry Moran and Michael T. McCaul disclosed DVA transactions in the filings shown here.

Which members of Congress hold DVA?

2 members of Congress report a position in DVA in the estimate we hold as of Nov 15, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

Is DVA in the S&P 500 or the Nasdaq 100?

DaVita Inc. is a current member of the S&P 500, per the membership list we hold as of Nov 16, 2026. Current members of either index get a page here whatever their filing history.

How quickly are DVA trades disclosed?

Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 33 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track